Furthermore, EZH2 is a direct target of miR-26a in docetaxel resistance cells, which could significantly suppress proliferation, facilitate apoptosis, inhibit the metastasis ability, and reverse EMT to mesenchymal–epithelial transition in lung adenocarcinoma cells (39). This evidence concerns the gene EZH2 and lung adenocarcinoma.